JDK Introduces Breakthrough Application of Polyethylene Glycol 4000 (Peg4000) in Pharmaceutical Intermediates
JDK, a leading company in the development of pharmaceutical intermediates and basic chemi
JDK Announces Launch of Vitamin D3 100,000 IU Supplement
With a professional team equipped with specialized and interdisciplinary technical talents, JDK has been focusing on the development of pharma
JDK Introduces Vitamin H, Expanding Its Range of Pharmaceutical Intermediates and Basic Chemicals
[JDK] is pleased to announce the introduction of Vitamin H to its extensive range of pharmaceutical i
JDK, a leading pharmaceutical company with a focus on the development of pharmaceutical intermediates and basic chemicals, has announced the launch of a new product - Vitamin B2. This announcement com
JDK, a leading pharmaceutical company specializing in the development of pharmaceutical intermediates and basic chemicals, has announced the launch of a new product - a 50% Acetylisovaleryltylosin Tar
The use of Vitamin E Acetate 50% has been a topic of discussion in the pharmaceutical industry, especially in the development of pharmaceutical intermediates and basic chemicals. With the increasing d
The use of Vitamin A Acetate 500,000 IU (International Units) in the pharmaceutical industry has been gaining significant attention in recent years. This valuable supplement has been utilized in a wid
Vitamin H, also known as biotin, is a water-soluble B-vitamin that plays a crucial role in the function of the human body. It is essential for maintaining healthy skin, hair, and nails, as well as for
JDK, a company renowned for its professional team and specialized technical talents, has made a significant breakthrough in the development of pharmaceutical intermediates and basic chemicals. The lat
Innovative Pharmaceuticals Collaborates with JDK for the Development of L-Theanine
Seattle, WA - Innovative Pharmaceuticals, a leading pharmaceutical company, has announced a collaboration with JDK,